SCHEMBL29022616

SCHEMBL29022616

C#CCNC(=O)c1ccc(OC(N)=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.59
▸ CA2 P00918 2/20 0.59
▸ CA12 O43570 1/20 0.59
▸ CA9 Q16790 1/20 0.59
▸ CA14 Q9ULX7 1/20 0.59
▸ SCD O00767 1/20 0.46
▸ NAMPT P43490 1/20 0.44
▸ NPC1 O15118 4/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ KMT2A Q03164 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ PKM P14618 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CACNA1B Q00975 1/20 0.41
▸ APBA1 Q02410 1/20 0.41
▸ KIF11 P52732 1/20 0.41
▸ MMP13 P45452 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12421889 0.82 NPC1 (0.49) CA1CA2CA12CA9NPC1
SCHEMBL4818576 0.82 RAB9A (0.63) CA1CA2CA12CA9CA14
SCHEMBL18364957 0.82 CA12 (0.52) CA1CA2CA12CA9CA14
SCHEMBL28856783 0.82 CA2 (0.68) CA1CA2CA12CA9CA14
SCHEMBL7210123 0.78 CA12 (0.68) CA1CA2CA12CA9CA14
SCHEMBL28424059 0.78 HPGD (0.66) NAMPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL17479849 0.78 CA1 (0.63) CA1CA2CA9NPC1KMT2A
SCHEMBL22231444 0.77 MAPT (0.54) CA1CA2CA12CA9CA14
SCHEMBL18704333 0.77 ATM (0.64) CA1CA2CA12CA9CA14
SCHEMBL17670798 0.77 EPHX2 (0.59) CA1CA2CA12CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN disclosed
Send feedback